Search research articles
Contact Us
Filters
Showing results (281-290 of 359) with videos related to
Page
of 36
Sort By:
Transplantation and Cellular Therapy
|
August 19, 2023
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
Ziheng Xu, Jaebok Choi, Matthew Cooper, et al.
Frontiers in Aging Neuroscience
|
May 6, 2014
Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, et al.
Blood Advances
|
October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001
Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
Blood
|
November 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Ramzi Abboud, Mark A Schroeder, Michael P Rettig, et al.
Bone Marrow Transplantation
|
July 19, 2016
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation
J Magenau, P Westervelt, S Khaled, et al.
Leukemia & Lymphoma
|
January 20, 2021
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes
Eric Huselton, Michael P Rettig, Theresa Fletcher, et al.
Cell
|
April 2, 2019
Steroid Hormone Function Controls Non-competitive Plasmodium Development in Anopheles
Kristine Werling, W Robert Shaw, Maurice A Itoe, et al.
Blood
|
March 16, 2017
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
Mark A Schroeder, Michael P Rettig, Sandra Lopez, et al.
Frontiers in Neurology
|
March 18, 2022
Relaxation-Compensated Chemical Exchange Saturation Transfer MRI in the Brain at 7T: Application in Relapsing-Remitting Multiple Sclerosis
Kristin P O'Grady, Sanjana Satish, Quinn R Owen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2021
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
Ryotaro Nakamura, Wael Saber, Michael J Martens, et al.
Page
of 36
Search research articles
Search
Showing results (281-290 of 359) with videos related to
Sort By:
Page
of 36
Transplantation and Cellular Therapy
|
August 19, 2023
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
Ziheng Xu, Jaebok Choi, Matthew Cooper, et al.
Frontiers in Aging Neuroscience
|
May 6, 2014
Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, et al.
Blood Advances
|
October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001
Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
Blood
|
November 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Ramzi Abboud, Mark A Schroeder, Michael P Rettig, et al.
Bone Marrow Transplantation
|
July 19, 2016
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation
J Magenau, P Westervelt, S Khaled, et al.
Leukemia & Lymphoma
|
January 20, 2021
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes
Eric Huselton, Michael P Rettig, Theresa Fletcher, et al.
Cell
|
April 2, 2019
Steroid Hormone Function Controls Non-competitive Plasmodium Development in Anopheles
Kristine Werling, W Robert Shaw, Maurice A Itoe, et al.
Blood
|
March 16, 2017
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
Mark A Schroeder, Michael P Rettig, Sandra Lopez, et al.
Frontiers in Neurology
|
March 18, 2022
Relaxation-Compensated Chemical Exchange Saturation Transfer MRI in the Brain at 7T: Application in Relapsing-Remitting Multiple Sclerosis
Kristin P O'Grady, Sanjana Satish, Quinn R Owen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2021
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
Ryotaro Nakamura, Wael Saber, Michael J Martens, et al.
Page
of 36